Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment

EY Choi, E Chavakis, MA Czabanka, HF Langer… - science, 2008 - science.org
EY Choi, E Chavakis, MA Czabanka, HF Langer, L Fraemohs, M Economopoulou
science, 2008science.org
Leukocyte recruitment to sites of infection or inflammation requires multiple adhesive events.
Although numerous players promoting leukocyte-endothelial interactions have been
characterized, functionally important endogenous inhibitors of leukocyte adhesion have not
been identified. Here we describe the endothelially derived secreted molecule Del-1
(developmental endothelial locus–1) as an anti-adhesive factor that interferes with the
integrin LFA-1–dependent leukocyte-endothelial adhesion. Endothelial Del-1 deficiency …
Leukocyte recruitment to sites of infection or inflammation requires multiple adhesive events. Although numerous players promoting leukocyte-endothelial interactions have been characterized, functionally important endogenous inhibitors of leukocyte adhesion have not been identified. Here we describe the endothelially derived secreted molecule Del-1 (developmental endothelial locus–1) as an anti-adhesive factor that interferes with the integrin LFA-1–dependent leukocyte-endothelial adhesion. Endothelial Del-1 deficiency increased LFA-1–dependent leukocyte adhesion in vitro and in vivo. Del-1–/– mice displayed significantly higher neutrophil accumulation in lipopolysaccharide-induced lung inflammation in vivo, which was reversed in Del-1/LFA-1 double-deficient mice. Thus, Del-1 is an endogenous inhibitor of inflammatory cell recruitment and could provide a basis for targeting leukocyte-endothelial interactions in disease.
AAAS